Novo Nordisk’s Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage

[ad_1]

That decision could widen insurance coverage for the drug and similar treatments for obesity, which has been a major barrier to access for patients.

[ad_2]

Source link